Literature DB >> 7181497

Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.

C Watanakunakorn, J C Tisone.   

Abstract

By the time-kill method, the combinations of nafcillin plus rifampin and oxacillin plus rifampin were antagonistic against 20 strains of Staphylococcus aureus. No synergism was demonstrated.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7181497      PMCID： PMC185687          DOI： 10.1128/AAC.22.5.920

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  Comparison of the antibacterial activity of rifampicin and other antibiotics.

Authors:  W R McCabe; V Lorian
Journal:  Am J Med Sci       Date:  1968-10       Impact factor: 2.378

3.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

4.  Antistaphylococcal activity of rifampin with other antibiotics.

Authors:  S H Zinner; H Lagast; J Klastersky
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

5.  Interaction between vancomycin and rifampin against Staphylococcus aureus.

Authors:  C Watanakunakorn; J C Guerriero
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

6.  Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.

Authors:  M A Sande; M L Johnson
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

7.  Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.

Authors:  C Watanakunakorm; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191
  7 in total
  5 in total

1.  Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.

Authors:  Cristina El Haj; Oscar Murillo; Alba Ribera; Mireia Vivas; Dolors Garcia-Somoza; Fe Tubau; Javier Cabo; Javier Ariza
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

2.  In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae.

Authors:  T Jadavji; C G Prober; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

3.  In vitro activities of rifapentine and rifampin, alone and in combination with six other antibiotics, against methicillin-susceptible and methicillin-resistant staphylococci of different species.

Authors:  P E Varaldo; E Debbia; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 4.  Rifampin combination therapy for nonmycobacterial infections.

Authors:  Graeme N Forrest; Kimberly Tamura
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

Review 5.  Pleiotropic Effects of Statins: New Therapeutic Approaches to Chronic, Recurrent Infection by Staphylococcus aureus.

Authors:  Melissa D Evans; Susan A McDowell
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.